BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32877987)

  • 21. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
    Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
    Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Human Platelet Lysate in Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells.
    Vennila R; Raja Sundari M Sundaram ; Selvaraj S; Srinivasan P; Pathak S; Rupert S; Rajagopal S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1177-1191. PubMed ID: 30819088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
    Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy.
    Abbaszadeh H; Ghorbani F; Derakhshani M; Movassaghpour AA; Yousefi M; Talebi M; Shamsasenjan K
    J Cell Physiol; 2020 Dec; 235(12):9230-9240. PubMed ID: 32557631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.
    Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Jeschke MG
    Stem Cells Transl Med; 2014 Mar; 3(3):299-307. PubMed ID: 24436441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wharton's Jelly stem cells: future clinical applications.
    Taghizadeh RR; Cetrulo KJ; Cetrulo CL
    Placenta; 2011 Oct; 32 Suppl 4():S311-5. PubMed ID: 21733573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
    Pu L; Meng M; Wu J; Zhang J; Hou Z; Gao H; Xu H; Liu B; Tang W; Jiang L; Li Y
    Stem Cell Res Ther; 2017 Mar; 8(1):72. PubMed ID: 28320452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
    Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
    J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene screening of Wharton's jelly derived stem cells.
    Mechiche Alami S; Velard F; Draux F; Siu Paredes F; Josse J; Lemaire F; Gangloff SC; Graesslin O; Laurent-Maquin D; Kerdjoudj H
    Biomed Mater Eng; 2014; 24(1 Suppl):53-61. PubMed ID: 24928918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis.
    Chinnici CM; Iannolo G; Cittadini E; Carreca AP; Nascari D; Timoneri F; Bella MD; Cuscino N; Amico G; Carcione C; Conaldi PG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
    Fong CY; Subramanian A; Biswas A; Bongso A
    J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton's Jelly.
    Sypecka M; Bzinkowska A; Sulejczak D; Dabrowski F; Sarnowska A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.
    Shin S; Lee J; Kwon Y; Park KS; Jeong JH; Choi SJ; Bang SI; Chang JW; Lee C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
    Prieto CP; Ortiz MC; Villanueva A; Villarroel C; Edwards SS; Elliott M; Lattus J; Aedo S; Meza D; Lois P; Palma V
    Stem Cell Res Ther; 2017 Feb; 8(1):43. PubMed ID: 28241866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs).
    Lech W; Sarnowska A; Kuczynska Z; Dabrowski F; Figiel-Dabrowska A; Domanska-Janik K; Buzanska L; Zychowicz M
    Sci Rep; 2020 Oct; 10(1):16946. PubMed ID: 33037314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.